Genomenon
Genomic Intelligence for Rare Disease and Cancer
ABOUT US
Genomenon is a genomics intelligence company in the lead position to be the first to curate the entire human genome. Our team is dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer.
Blending the power of AI with the precision of genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development.
Our solutions include:
OUR STORY
Genomenon, a name signifying “born out of need” in ancient Greek, perfectly encapsulates the genesis of our journey.
In his clinical practice and genomic research, co-founder Dr. Mark Kiel was frustrated with the painfully slow and time-consuming process of manual curation. He was also well aware of the diagnostic odyssey that thousands of rare disease patients and families face as he and his twin brother had hypodontia, or missing adult teeth, in their youth. Living with a rare condition as a child focused Mark’s attention on genetics, and his desire to make an impact on rare diseases.
Genomenon was founded in 2014 to address this pressing need for faster, more comprehensive variant interpretation by combining expert curation with unique machine-learning methods designed to keep up with the pace of new publications and present the most relevant information to researchers.
Today, Genomenon empowers scientists and researchers at pharmaceutical companies, clinical labs, and universities to more thoroughly understand diseases at a molecular level.
Genomenon is headquartered in Ann Arbor, Michigan.
MEET THE TEAM
Mike Klein CEO
With over 25 years of developing, building and growing 4 different high-tech companies, Mike raised over $50M in capital and had several successful investor exits.
Mark J. Kiel, MD, PhD CSO & Co-Founder
Mark has extensive experience in genome-sequencing and clinical data analysis underlying the vision and technology driving the Genomenon suite of software tools.
Sean Kearney CFO
Always seeking opportunities for growth, Sean has spent his career investing in and scaling innovative platforms in genomics, telemedicine and healthcare delivery.
Sam Globus, PhD COO
Sam brings a wealth of experience in genomic product development and operations to the team, and manages the rapid growth of our data science and variant curation work.
Brittnee Jones, PhD VP, Product Management & Customer Success
Brittnee has spent over a decade building and leading customer success teams across the NGS space, ensuring rapid product adaption and maximal value for customers.
Jon Murray VP of Sales
Jon has been in the informatics market for over 25 years. He brings a track record of successful sales management and team building.
Colleen McMillen VP, Marketing
Colleen is an accomplished communications and marketing executive in the health space with more than two decades of experience delivering high-impact positioning for products, organizations and executive teams.
Arslan Berbic VP, Business Development
As CEO of Boston Genetics (now part of Genomenon) Arslan brings a deep understanding of building and managing meaningful customer relationships in the diagnostic lab domain.
Candace Chapman VP, Clinical Marketing
Candace has 25 years experience in enterprise and high-tech marketing and brings both strategic leadership and tactical execution to the team.
Dave Anstey VP, Pharma Business Development
Dave has almost 30 years of experience selling scientific software with a track record of building successful sales teams and meaningful customer relationships.
Jonathan Eads VP, Engineering
Jonathan brings 25 years of experience in genomics, drug discovery, bioinformatics, and AI/ML software application development, with extensive experience building and leading engineering teams to deliver operational excellence.
Marc Fink, PhD Director of Biological Data Science
Marc drives innovation with his bioinformatics, genetics, pharmacology, and data science expertise, gained from over 15 years in academia and genomic companies.
Ronda Bergman Director of Engineering
Ronda has spent more than 20 years working in software development in a variety of roles, from strategy execution to building effective teams.
Steve Schwartz Co-founder & Advisor
Steve has co-founded several successful web-based software start-ups. He brings to the team deep domain expertise and extensive start-up experience.
Kojo Elenitoba-Johnson, MD CO-FOUNDER & ADVISOR
Kojo is the Director for Precision and Computational Diagnostics at University of Pennsylvania Perelman School of Medicine and President of the Association of Molecular Pathology.
Megan Lim, MD, PhD CO-FOUNDER & ADVISOR
Megan is the Director of the Hematopathology and Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania.
Every accolade is a testament to our team and our mission to make genomic information actionable
CAREERS AT GENOMENON
Click on our current open positions to learn more and apply.
An “A player” salesperson who is adept in all aspects of B2B sales with experience building a sales pipeline to successful close of business to achieve the company’s revenue goals. Prior sales management experience is an asset as we grow our business. You will have an opportunity to play a key role for the company to achieve its goals and will have access to the rest of the leadership team to help us build an industry leading company. Apply Here
We are seeking a remote-based Senior Product Manager to be responsible for the commercial objectives and success of a new product area at Genomenon. As a Senior Product Manager, you will play a crucial role in driving the development and launch of cutting-edge genomics solutions for clinical diagnostics labs and pharma that have a significant impact on patient care and drug development. We are seeking a data-driven, adaptable, self-starter to work cross-functionally with all areas of the organizations. The senior product manager will own the product life-cycle from customer KOL insight through post-market surveillance and product expansion. In this role, you will be responsible for overseeing the entire product lifecycle, from ideation to launch, for our genomics solutions. You will collaborate closely with cross-functional teams, including engineering, data science, clinical research, and business development, to ensure the successful execution of our product strategy. Apply Here
OUR CORE VALUES
Always Learning
We approach challenges with curiosity and a growth mindset
Data Driven
We ask questions and look to the evidence for answers
Trailblazers
We focus on what can be – not what is
Humbly Confident
We have confidence in who we are, where we're going, and how we're getting there
True Grit
We embody passion, persistence, and aren't afraid of hard work
Citing Mastermind
When citing use of the Mastermind Genomic Intelligence Platform, use the following text:
Mastermind Genomic Intelligence Platform (https://www.genomenon.com/mastermind)
Details on the Mastermind research paper published in November of 2020:
PubMed: https://pubmed.ncbi.nlm.nih.gov/33281875/
DOI: https://doi.org/10.3389/fgene.2020.577152
Citation: Chunn LM, Nefcy DC, Scouten RW, Tarpey RP, Chauhan G, Lim MS, Elenitoba-Johnson KSJ, Schwartz SA, Kiel MJ. Mastermind: A Comprehensive Genomic Association Search Engine for Empirical Evidence Curation and Genetic Variant Interpretation. Front Genet. 2020 Nov 13;11:577152. doi: 10.3389/fgene.2020.577152. PMID: 33281875; PMCID: PMC7691534.
MASTERMIND GENOMIC INTELLIGENCE PLATFORM
Say Goodbye to CTRL F
Say Goodbye to CTRL F